Top content from this year's CHEST meeting in Chicago focused on bronchiectasis treatment, particularly the newly FDA-approved brensocatib (Brinspuri; Insmed). Brensocatib improves lung structure and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results